MEDXvsETF 2ETF Comparison
VS
ETF 2
Choose a second ETF to run a side-by-side ETF comparison with MEDX, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
MEDX performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 06/18/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | MEDX ETF 2 | +4.22%– | +4.42%– | +1.90%– | +28.39%– | +18.69%– | n/a– |
| Flows | MEDX ETF 2 | -$853K– | -$2M– | -$2M– | -$2M– | -$3M– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | MEDX ETF 2 | +18.73%– | +17.76%– | +16.85%– | n/a– |
| Max drawdown | MEDX ETF 2 | -5.88%– | -10.65%– | -23.05%– | n/a– |
| Max drawdown duration | MEDX ETF 2 | 55d– | 109d– | 393d– | n/a– |
Trading data
MEDX | ETF 2 | |
Last sale 6/18/2026 at 1:30 PM | $33.88 | – |
| Previous close 06/18/2026 | $34.23 | – |
| Consolidated volume 06/18/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 6/18/2026 at 1:30 PM
Live
Closed
MEDX | ETF 2 | |
|---|---|---|
| Last price | $33.88 | – |
| 1D performance | -1.02% | – |
| AuM | $17.61 M | – |
| E/R | 0.85% | – |
Characteristics
MEDX | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | Horizon Kinetics LLC | – |
| Benchmark | - | – |
| N° of holdings | 25 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | January 27, 2023 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
MEDX
USA
78.22%
Other
21.78%
ETF 2
Sectors
MEDX
Health Care
78.89%
Other
21.11%
ETF 2
Advertisement
Diversification
MEDX
Total weight of top 15 holdings out of 15
80.85%
ETF 2
–
Top 15 holdings
Data as of April 30, 2026
MEDX
LILLY
15.38%
ABBVIE
7.99%
US66987V1098
7.30%
JOHNSON&JOHNSON
5.71%
ASTRAZENECA
5.67%
BRISTOL-MYERS SQUIBB
5.10%
IONIS PHARMACEUTICALS INC
4.75%
AMGEN-T
4.23%
ALKERMES
4.10%
ALNYLAM PHARMACEUTICALS
4.03%
MERCK & CO INC
3.90%
PFIZER
3.66%
US37733W2044
3.22%
BIOGEN INC
2.97%
CRISPR THERAPEUTICS
2.84%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
